--- title: "Shouxiangu: Wholly-owned subsidiary's products complete domestic health food filing" type: "News" locale: "en" url: "https://longbridge.com/en/news/242889849.md" description: "On the evening of June 3rd, Shouxiangu announced that its wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd.'s product \"Shouxiang Liangpin® Broken Wall Ganoderma Spore Powder\" has completed the filing work for domestic health food and has obtained the domestic health food filing certificate issued by the Zhejiang Provincial Market Supervision Administration" datetime: "2025-06-03T08:23:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/242889849.md) - [en](https://longbridge.com/en/news/242889849.md) - [zh-HK](https://longbridge.com/zh-HK/news/242889849.md) generator: "portal-rs" --- # Shouxiangu: Wholly-owned subsidiary's products complete domestic health food filing On the evening of June 3rd, Shouxiangu announced that its wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd. has completed the filing work for its "Shouxiang Liangpin® Broken Wall Ganoderma Spore Powder" product as a domestic health food and has obtained the domestic health food filing certificate issued by the Zhejiang Provincial Market Supervision Administration ### Related Stocks - [603896.CN](https://longbridge.com/en/quote/603896.CN.md) ## Related News & Research - [PING AN Confident of Better Full-Yr NBV Growth; Overseas Policy Gain Tax Impact Nearly Zero](https://longbridge.com/en/news/296570673.md) - [Ping An Insurance (Group) Company of China: Net profit surged 36.1% YoY to RMB92.6bn; interim dividend up 3.2% to RMB0.98/share](https://longbridge.com/en/news/296469307.md) - [Ping An Insurance Declares Interim Dividend and Sets Tax Terms for Investors](https://longbridge.com/en/news/296477996.md) - [PING AN 1H26 Net Profit Up 36.1% to RMB92.585B; Interim DPS Hikes 3.2% to RMB0.98](https://longbridge.com/en/news/296473576.md) - [Chinese insurer Ping An’s profit rises 36% on policy sales, investments](https://longbridge.com/en/news/296488170.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**